This grant supports activities that enable or contribute to the development and use of new bio-printing technologies for regenerative medicine. The aim is to provide biomedical scientists, healthcare professionals, and providers with advanced bio-printing units and equipment for regenerative medicine, enabling personalised therapies and addressing unmet medical needs. The focus is on tissue-specific functional 3D bio-printing of living cells, both in-vitro and in-situ, to repair or regenerate defective tissues or organs. Proposals must use human cells and cover the development of GMP-compliant equipment, regulatory steps for clinical studies, and assessment in first in-human studies. Regulatory compliance with EU frameworks on medical devices, ATMPs, and Substances of Human Origin is required. Multidisciplinary teams, including SMEs, are encouraged to apply.
| Agency | HORIZON (EU) |
|---|---|
| Region | EU |
| Country | N/A |
| Legal form | Company, NGO, Government organization, Private person, Other |
| Start date | 3 Jun 2027 |
| End date | 22 Sep 2027 |
| Max funding | HORIZON-RIA (Research and Innovation Actions): EUR 7,000,000 - EUR 10,000,000 per project (expected approx. 4 grants), HORIZON-CSA (Coordination and Support Actions): EUR 2,900,000 (expected 1 grant), HORIZON-RIA (Research and Innovation Actions): EUR 10,000,000 - EUR 12,000,000 per project (expected approx. 4 grants) |
| Budget | EUR 39,300,000 allocated for RIA (Research and Innovation Actions) in 2027 EUR 2,900,000 allocated for CSA (Coordination and Support Actions) in 2027 |